Nav: Home

David Glahn given the ACNP Joel Elkes Research Award

December 05, 2016

The American College of Neuropsychopharmacology (ACNP) has named David Glahn, Ph.D., Professor of psychiatry and Co-Director of the Division on Neurocognition, Neurocomputation and Neurogenetics at Yale University School of Medicine as the winner of the Joel Elkes Research Award. This award, presented at the 55th Annual Meeting of the ACNP in Hollywood, Florida, is in recognition of an outstanding clinical contribution to neuropsychopharmacology. In nominating Dr. Glahn for the award, Dr. John Krystal, Chair of the Department of Psychiatry at Yale, called him a "strikingly original and productive scientist", a "dynamic teacher", and "an outstanding mentor".

Dr. Glahn has published over 200 papers and reviews in leading scientific journals, leads a number of research grants funded by the National Institutes of Health, and has played a seminal role in building and leading imaging-genomics consortia to advance the analytic methods for the enormous datasets involved in whole genome sequencing. The power of Dr. Glahn's approach is that he uses function to search for structure. That is, he utilizes his deep knowledge of cognitive neuroscience to nominate potential biomarkers, which can then be studied in large pedigree cohorts to assess heritability, reveal disease associations, and identify putative risk genes. This approach helps to ensure that identified risk genes are likely to have a meaningful impact on the daily functioning of the individual, eliminating the need to conduct a post-hoc search to ascribe function. In addition, Dr. Glahn served as a Section Editor for Human Brain Mapping and currently serves on the editorial board of three other professional journals. He is a Fellow in the ACNP, and has been the recipient of a number of other professional honors, including the A. E. Bennett Award of the Society of Biological Psychiatry.
-end-
Media contact: Erin Colladay at ecolladay@acnp.org; 615-649-3074

ACNP, founded in 1961, is a professional organization of more than 1000 leading scientists, including four Nobel Laureates. The mission of ACNP is to further research and education in neuropsychopharmacology and related fields in the following ways: promoting the interaction of a broad range of scientific disciplines of brain and behavior in order to advance the understanding of prevention and treatment of disease of the nervous system including psychiatric, neurological, behavioral and addictive disorders; encouraging scientists to enter research careers in fields related to these disorders and their treatment; and ensuring the dissemination of relevant scientific advances.

American College of Neuropsychopharmacology

Related Medicine Articles:

Moving beyond 'defensive medicine'
Study shows removing liability concerns slightly increases C-section procedures during childbirth.
Artificial intelligence and family medicine: Better together
Researcher at the University of Houston are encouraging family medicine physicians to actively engage in the development and evolution of artificial intelligence to open new horizons that make AI more effective, equitable and pervasive.
NUS Medicine researchers can reprogramme cells to original state for regenerative medicine
Scientists from NUS Medicine have found a way to induce totipotency in embryonic cells that have already matured into pluripotency.
Protein injections in medicine
One day, medical compounds could be introduced into cells with the help of bacterial toxins.
Study reveals complementary medicine use remains hidden to conventional medicine providers
Research reveals that 1 in 3 complementary medicine (CM) users do not disclose their CM use to their medical providers, posing significant direct and indirect risks of adverse effects and harm due to unsafe concurrent use of CM and conventional medicine use.
Study of traditional medicine finds high use in Sub-Saharan Africa despite modern medicine
Researchers who have undertaken the first systematic review of into the use of traditional, complementary and alternative medicines (TCAM) in Sub-Saharan Africa found its use is significant and not just because of a lack of resources or access to 'conventional medicine'.
New techniques allow medicine to see the whole again
Medical diagnoses mostly focuses on resolving isolated issues. But, fixing one problem may create others and even invoke an overall health collapse.
Progress toward personalized medicine
A few little cells that are different from the rest can have a big effect.
CU School of Medicine's Kenneth Tyler article in New England Journal of Medicine
Kenneth Tyler, M.D., the Louise Baum Endowed Chair in Neurology at the University of Colorado School of Medicine, is author of a review article about acute viral encephalitis in the current issue of The New England Journal of Medicine.
An advance for precision medicine
Scientists have developed a method to quickly and efficiently recognize the subtypes of cells within the body for the first time.
More Medicine News and Medicine Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.